Comparison of hormonal receptor and HER-2 status between breast primary tumours and relapsing tumours: clinical implications of progesterone receptor loss

by Bogina, Giuseppe, Bortesi, Laura, Marconi, Marcella, Venturini, Marco, Lunardi, Gianluigi, Coati, Francesca, Massocco, Alberto, Manfrin, Erminia, Pegoraro, Cristina, Zamboni, Giuseppe
Published 2011

Dose-Dense FEC Followed by Dose-Dense Ixabepilone as Neoadjuvant Treatment for Breast Cancer Patients: A Feasibility Study

by Clavarezza, Matteo, Bordonaro, Roberto, Daniele, Bruno, Ferrandina, Gabriella, Barni, Sandro, Turazza, Monica, Coati, Francesca, De Matteis, Andrea, De Placido, Sabino, Cognetti, Francesco, Olmeo, Nina Antonina, Carrozza, Francesco, Bruzzi, Paolo, Del Mastrol, Lucia
Published 2013

Dose-Dense FEC Followed by Dose-Dense Ixabepilone as Neoadjuvant Treatment for Breast Cancer Patients: A Feasibility Study

by Clavarezza, Matteo, Bordonaro, Roberto, Daniele, Bruno, Ferrandina, Gabriella, Barni, Sandro, Turazza, Monica, Coati, Francesca, De Matteis, Andrea, De Placido, Sabino, Cognetti, Francesco, Olmeo, Nina Antonina, Carrozza, Francesco, Bruzzi, Paolo, Del Mastro, Lucia
Published 2013